Skip to main content

Languages

  • العربية
  • 简体中文
  • English
  • Français
  • Русский
  • Español
Home
  • Browse States Parties
  • About CBM
  • CBM Guide
    • English
    • Chinese
    • French
    • Russian
    • Spanish
    • Arabic
  • Log in

You are here

Home » Canada » bwc_cbm_2019_Canada_Fr » Confidence-Building Measure G
Download

    Corporation ID Biomédical du Québec (GlaxoSmithKline Inc.)

    2. Location (mailing address)
    Québec (Québec)
    3. General description of the types of diseases covered

    Fabricant de vaccins destinés aux humains

    Report Index

    • Cover page declaration (“Form 0”)
    • A, part 1
    • A, part 2 (i)
    • A, part 2 (ii)
    • A, part 2 (iii)
    • B
    • C
    • E
    • F
    • G
        • Sanofi Pasteur Limited
        • Immunovaccine
        • Medicago
        • InventVac
        • Conseil national de recherches du Canada
        • Artemis Technologies Inc. (Perm. can. établ. prod. biol. vét. No 50)
        • Biovet Inc. (Perm. can. établ. prod. biol. vét. No 49)
        • Centre for Aquaculture Technologies Canada (Can. Vet. Biol. Estab. Lic. No. 61)
        • Ceva Animal Health (Perm. can. établ. prod. biol. vét. N° 23)
        • Elanco Canada Limited - Aqua Health (Perm. can. établ. prod. biol. vét. N° 40)
        •  
        • 1 of 2
        • next ›

    BWC Electronic Confidence Building Measures Portal

    Copyright (c) UNOG 2018

     

    Biological Weapons Convention Implementation Support Unit

    Palais des Nations, 1211 Geneva 10, Switzerland
    Phone: +41 (0)22 917 2230
    E-mail: bwc@un.org
    UN logo